Modulation of insulin secretion from beta-cells by phosphoinositide-derived second-messenger molecules

Modulation of insulin secretion from beta-cells by phosphoinositide-derived second-messenger molecules. W S Zawalich Yale University School of Nursing, New Haven, Connecticut 06536. Abstract In isolated islets, the hydrolysis of membrane phosphoinositides (PI) participates in the transduction of bot...

Full description

Saved in:
Bibliographic Details
Published inDiabetes (New York, N.Y.) Vol. 37; no. 2; pp. 137 - 141
Main Author Zawalich, W. S.
Format Journal Article
LanguageEnglish
Published American Diabetes Association 01.02.1988
Online AccessGet full text

Cover

Loading…
More Information
Summary:Modulation of insulin secretion from beta-cells by phosphoinositide-derived second-messenger molecules. W S Zawalich Yale University School of Nursing, New Haven, Connecticut 06536. Abstract In isolated islets, the hydrolysis of membrane phosphoinositides (PI) participates in the transduction of both extracellular and intracellular signals into an effective insulin secretory response. A wide variety of potential second-messenger molecules are generated during the phospholipase C-mediated cleavage of these strategically situated membrane phospholipids. Several distinct but interrelated issues are addressed in this perspective. These include 1) methodological approaches utilized to assess PI turnover, 2) the synergistic relationship between PI-derived second messengers and cAMP, 3) the contribution of changing PI turnover rates to the biphasic pattern of insulin output induced by 20 mM glucose, and 4) the role played by PI turnover in the phenomenon of "memory" displayed by islets after prior stimulation with various agonists. The concept that events unique to PI turnover contribute to beta-cell activation is well founded. Because of uncertainty regarding the exact nature of all PI-derived messengers, however, it is not yet possible to mold the available information into a comprehensive theory of beta-cell activation. Future studies will have to address various important unresolved issues.
ISSN:0012-1797
1939-327X
0012-1797
DOI:10.2337/diabetes.37.2.137